If your new iPad just started acting up, don't panic. You can actually fix most common iPad issues without paying for repairs ...

Zoom Communications owns up to $4B in Anthropic equity, offering a potential IPO-driven upside catalyst. Learn why ZM stock ...

Quantum Sails, as official Sailmaker to the Helly Hansen Sailing World Regatta Series, will deliver weather, coaching and ...

Cory Doctorow and Tim Wu explain why the internet failed to live up to its early promise.

The Redmi Note 15 Pro+ makes its case by being sensible where it matters most. It focuses on everyday strengths rather than ...

Sitting between the Vivo X300 and previous generation X200 models, the Vivo X200T offers a sharp display, strong battery life, and balanced performance rather than headline-grabbing upgrades ...

None ...

The 1080p HD Video gadget is ideal for pet owners wanting to check on their furry companions remotely. Currently, it's ...

A new flagship webcam that can follow you – and might be premium enough to take on your pro camera?

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?